These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 23320123)
1. Treatment of Cutaneous Lupus Erythematosus: Review and Assessment of Treatment Benefits Based on Oxford Centre for Evidence-based Medicine Criteria. Winkelmann RR; Kim GK; Del Rosso JQ J Clin Aesthet Dermatol; 2013 Jan; 6(1):27-38. PubMed ID: 23320123 [TBL] [Abstract][Full Text] [Related]
2. Management of cutaneous manifestations of lupus erythematosus: A systematic review. Fairley JL; Oon S; Saracino AM; Nikpour M Semin Arthritis Rheum; 2020 Feb; 50(1):95-127. PubMed ID: 31526594 [TBL] [Abstract][Full Text] [Related]
3. Cutaneous lupus erythematosus: issues in diagnosis and treatment. Walling HW; Sontheimer RD Am J Clin Dermatol; 2009; 10(6):365-81. PubMed ID: 19824738 [TBL] [Abstract][Full Text] [Related]
7. A review of the evidence and cost of therapies for cutaneous lupus erythematosus. Rosen JD; Paul S; Maderal A Lupus; 2019 Jun; 28(7):799-805. PubMed ID: 31042129 [TBL] [Abstract][Full Text] [Related]
8. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
9. Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation. Tzellos TG; Kouvelas D Eur J Clin Pharmacol; 2008 Apr; 64(4):337-41. PubMed ID: 18157526 [TBL] [Abstract][Full Text] [Related]
10. The effectiveness and safety of biological therapeutics in juvenile-onset systemic lupus erythematosus (JSLE): a systematic review. Peterknecht E; Keasey MP; Beresford MW Lupus; 2018 Nov; 27(13):2135-2145. PubMed ID: 30336753 [TBL] [Abstract][Full Text] [Related]
11. Cutaneous lupus erythematosus: a personal approach to management. Callen JP Australas J Dermatol; 2006 Feb; 47(1):13-27. PubMed ID: 16405478 [TBL] [Abstract][Full Text] [Related]
13. Management of skin disease in patients with lupus erythematosus. Callen JP Best Pract Res Clin Rheumatol; 2002 Apr; 16(2):245-64. PubMed ID: 12041952 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic strategies evaluated by the European Society of Cutaneous Lupus Erythematosus (EUSCLE) Core Set Questionnaire in more than 1000 patients with cutaneous lupus erythematosus. Sigges J; Biazar C; Landmann A; Ruland V; Patsinakidis N; Amler S; Bonsmann G; Kuhn A; Autoimmun Rev; 2013 May; 12(7):694-702. PubMed ID: 23220353 [TBL] [Abstract][Full Text] [Related]
15. Cutaneous lupus erythematosus: diagnosis and management. Fabbri P; Cardinali C; Giomi B; Caproni M Am J Clin Dermatol; 2003; 4(7):449-65. PubMed ID: 12814335 [TBL] [Abstract][Full Text] [Related]
16. Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus. Sticherling M Biologics; 2011; 5():21-31. PubMed ID: 21383913 [TBL] [Abstract][Full Text] [Related]
17. Cutaneous lupus erythematosus: A review of the literature. Blake SC; Daniel BS Int J Womens Dermatol; 2019 Dec; 5(5):320-329. PubMed ID: 31909151 [TBL] [Abstract][Full Text] [Related]
18. Drugs for discoid lupus erythematosus. Jessop S; Whitelaw DA; Delamere FM Cochrane Database Syst Rev; 2009 Oct; (4):CD002954. PubMed ID: 19821298 [TBL] [Abstract][Full Text] [Related]
19. Review of treatment for discoid lupus erythematosus. Garza-Mayers AC; McClurkin M; Smith GP Dermatol Ther; 2016 Jul; 29(4):274-83. PubMed ID: 27073142 [TBL] [Abstract][Full Text] [Related]
20. The use of SLICC and ACR criteria to correctly label patients with cutaneous lupus and systemic lupus erythematosus. Flynn A; Gilhooley E; O'Shea F; Wynne B Clin Rheumatol; 2018 Mar; 37(3):817-818. PubMed ID: 29392510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]